PentaBase and Resnova sign a strategic agreement for SensiScreen®…
PentaBase and Resnova are pleased to announce their recent partnership agreement for the new exclusive distribution in Italy of PentaBase’ SensiScreen® test kit range conceived for the somatic mutation detection in cancer patients.
PentaBase ApS is a privately-owned Company founded in 2006, based in Odense (Denmark), rooted in the Intercalating Nucleic Acid invention, INA®.
Currently, INA® technology has been optimized, and includes proprietary monomers called “pentabases”. Such modified oligonucleotides show innovative and unique features that make them optimal for alternative approaches for genetic analysis. This platform has been used for the development of diagnostic kits, mainly based on the real-time PCR technique.
Resnova S.r.l. is an Italian, Rome-based, Distribution Company that, for over 21 Years of active presence in the Italian Marketplace, has acquired a leading position, on the entire Italian Territory. Its wide range portfolio of innovative solutions for in the Molecular Cytogenetic, Molecular and Cellular Biology fields for Advanced Diagnostics and Research/Biotechnologies Laboratories is obtained as result of alliances and exclusive distributor partnerships established with selected and innovating Biotech Companies worldwide.
“We found that Resnova, thanks to its long–lasting experience and specialization in the Molecular Advanced Diagnostics field, represents the ideal partner for our growth in Italy”, said Ulf Bech Christensen, Founder and CEO at PentaBase. “Resnova’s Team, thanks to the strong experience and active presence, will help PentaBase to offer Italian scientists and researchers, operating in Diagnostics Labs, a capillary and specialized technical support for the enhancement of innovative PentaBase Products diffusion in the Italian marketplace”
“We are very excited about the perspective to further expand our range of activities into the oncology field by partnering with an innovative Company focused on the development and commercialization of a new generation of molecular diagnostics tools, that combine ultra-high sensitivity with multiplexing capabilities, in full continuity with our existing successful distribution experiences and range of solutions”, said Sergio Centanaro, Managing Director at Resnova.
For further information or details please contact one of PentaBase or Resnova’s Representatives to the below listed addresses:
- Ulf Bech Christensen
ubc@pentabase.com
https://www.pentabase.com
- Sergio Centanaro
scent@resnovaweb.it
http://www.resnovaweb.com